|
Betsy Blake, PharmD, BCPS; Director of Interprofessional Education and Clinical Associate Professor, University of South Carolina College of Pharmacy; Co-Chair, Interprofessional Education for the Health Sciences, University of South Carolina
|
Overcoming Migraines: Novel Medications to Treat and Prevent Migraines
|
Educational Objectives:
After completing this program, the pharmacist will be able to: 1. Describe migraine headaches and the criteria for diagnosis
2. Discuss lifestyle modifications to decrease migraine episodes 3. Review the evidence for new and existing therapies to treat and prevent migraines 4. Demonstrate the appropriate administration of injectable migraine therapies |
||
|
Michaela Almgren, PharmD, MS; Clinical Assistant Professor,
University of South Carolina College of Pharmacy
|
New Approaches to Pain Management: Multimodal Opioid-Free Analgesia
|
Educational Objectives: After completing this program, the pharmacist will be able to: 1. Review the impact of the opioid epidemic in the U.S. and SC 2. Discuss the pathophysiology of pain 3. Describe different types of pain and current treatment protocols 4. Define preemptive, preventive and multimodal analgesia 5. Explain the use of multimodal analgesia as an alternative to opioids |
||
|
Karen McGee, PharmD, CDE, BCGP; Clinical Associate Professor, University of South Carolina College of Pharmacy; Clinical Pharmacist, Palmetto SeniorCare PACE
|
Dementia and Behavioral Disturbances in the Geriatric Population
|
Educational Objectives: After completing this program, the pharmacist will be able to: 1. Classify common types of dementia 2. Review medications of choice for memory loss and agitation associated with dementia 3. Evaluate patient cases and develop care plans that emphasize patient safety |
||
|
Patricia H. Fabel, PharmD, BCPS; Executive Director, Kennedy Pharmacy Innovation Center; Clinical Associate Professor, University of South Carolina College of Pharmacy
|
The Value of Integrating Pharmacists into Primary Care
|
Educational Objectives: After completing this program, the pharmacist will be able to: 1. Recognize the benefit of incorporating a pharmacist into primary care settings for the management of high blood pressure, high cholesterol and diabetes 2. Describe the economic feasibility of integrating a pharmacist into primary care settings |
||
|
Brandon Bookstaver, PharmD, FCCP, FIDSA, BCPS; Associate Professor and Director of Residency & Fellowship Training, University of South Carolina College of Pharmacy; Infectious Diseases PGY2 and Clinical Fellowship Director, USC/Prisma Health Richland
|
Top 10 Infectious Diseases Topics of 2019
|
Educational Objectives: After completing this program, the pharmacist will be able to: 1. Apply updated infectious diseases treatment guidelines and policies to antimicrobial recommendations 2. Analyze clinical implications of peer-reviewed infectious diseases literature 3. Determine the role of newly approved antimicrobials 4. Acknowledge emerging pathogens both nationally and globally 5. Discuss changes in roles and responsibilities of pharmacists in managing infectious diseases |
|
Hours | Pharmacists |
Entire Program:
To Purchase the entire program,
click on "Purchase Now" below!
|
7 hours
|
$75 |
Individual Sessions
To purchase individual sessions, check the session(s) you would like to purchase on the list below!
|
1-6 hours | $15 per session |
- Fees will appear as “Learning Express” on your credit card statement
- Operating System: Windows, Mac OS and Linux
- Internet Browser: Internet Explorer 7.0 or higher; Mozilla Firefox 3.0 or higher; Google Chrome
- Computer Speakers or headphones connected to your computer
- Broadband Internet Connection: Cable, High-speed DSL or T1
- Monitor Screen Resolution: 320x480 or higher
- Media Viewing Requirements: Adobe Reader, Adobe Flash Player, Microsoft Power Point and HTML
Fee
CE Hours
CE Units
Activity Type
- Knowledge-Based and Application-Based
Target Audience(s)
- Pharmacists
Accreditation(s)
The University of South Carolina College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
|
Requirements for CE Credit
Support/Credits
- Describe migraine headaches and the criteria for diagnosis
- Discuss lifestyle modifications to decrease migraine episodes
- Review the evidence for new and existing therapies to treat and prevent migraines
- Demonstrate the appropriate administration of injectable migraine therapies
Speaker(s)/Author(s)
Betsy Blake, PharmD, BCPS, FNAP
|
Activity Number
0062-0000-20-002-H01-P
CE Hours
Fee
- Review the impact of the opioid epidemic in the U.S. and SC
- Discuss the pathophysiology of pain
- Describe different types of pain and current treatment protocols
- Define preemptive, preventive and multimodal analgesia
- Explain the use of multimodal analgesia as an alternative to opioids
Speaker(s)/Author(s)
Michaela Almgren, PharmD, MS
|
Activity Number
0062-0000-20-003-H01-P
CE Hours
Fee
- Classify common types of dementia
- Review medications of choice for memory loss and agitation associated with dementia
- Evaluate patient cases and develop care plans that emphasize patient safety
Speaker(s)/Author(s)
Karen McGee, PharmD, CDCES, BCGP
|
Activity Number
0062-0000-20-004-H01-P
CE Hours
Fee
- Recognize the benefit of incorporating a pharmacist into primary care settings for the management of high blood pressure, high cholesterol and diabetes
- Describe the economic feasibility of integrating a pharmacist into primary care settings
Speaker(s)/Author(s)
Patricia Fabel, PharmD, BCPS
|
Activity Number
0062-0000-20-005-H04-P
CE Hours
Fee
- Apply updated infectious diseases treatment guidelines and policies to antimicrobial recommendations
- Analyze clinical implications of peer-reviewed infectious diseases literature
- Determine the role of newly approved antimicrobials
- Acknowledge emerging pathogens both nationally and globally
- Discuss changes in roles and responsibilities of pharmacists in managing infectious diseases
Speaker(s)/Author(s)
P. Brandon Bookstaver, PharmD, FCCP, FIDSA
|
Activity Number
0062-0000-20-006-H01-P